Back
WisdomTree Emerging Markets Ex-China Fund Vs. Ascendis Pharma AS Industry Stock Comparison
Sell
50
XC
WisdomTree Emerging Markets Ex-China Fund
Last Price:
$30.31
Seasonality Move:
4.69%
Sell
48
ASND
Ascendis Pharma AS
Last Price:
$164.03
Seasonality Move:
-9.72%
Sell
50
WisdomTree Emerging Markets Ex-China Fund (XC)
is a Sell
Is WisdomTree Emerging Markets Ex-China Fund a Buy, Sell or Hold?
-
The current WisdomTree Emerging Markets Ex-China Fund [XC] share price is $30.25. The Score for XC is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
XC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
48
Ascendis Pharma AS (ASND)
is a Sell
Is Ascendis Pharma AS a Buy, Sell or Hold?
-
The current Ascendis Pharma AS [ASND] share price is $164.65. The Score for ASND is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
ASND is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
XC Stock Price Chart
What is WisdomTree Emerging Markets Ex-China Fund's stock price today?
-
The WisdomTree Emerging Markets Ex-China Fund share price today is $30.25The current trend is relatively stagnant and XC is experiencing slight buying pressure.
ASND Stock Price Chart
What is Ascendis Pharma AS's stock price today?
-
The Ascendis Pharma AS share price today is $164.65Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ASND is experiencing selling pressure, which indicates risk of future bearish movement.
XC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.21 | Sell |
| Relative Strength Index (14 RSI): | 48.95 | Sell |
| Chaikin Money Flow: | 378 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (29.88 - 31.04) | Sell |
| Bollinger Bands (100): | (30.49 - 32.03) | Sell |
ASND Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.96 | Buy |
| Relative Strength Index (14 RSI): | 63.68 | Buy |
| Chaikin Money Flow: | -280747 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (135.08 - 160.62) | Buy |
| Bollinger Bands (100): | (124.26 - 145.68) | Buy |
XC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 30.05 | Buy |
| 20-day SMA: | 30.31 | Sell |
| 50-day SMA: | 30.71 | Sell |
| 200-day SMA: | 31.82 | Sell |
| 8-day EMA: | 30.13 | Buy |
| 20-day EMA: | 30.27 | Sell |
| 50-day EMA: | 30.67 | Sell |
| 200-day EMA: | 31.13 | Sell |
ASND Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 154.01 | Buy |
| 20-day SMA: | 153.39 | Buy |
| 50-day SMA: | 139.38 | Buy |
| 200-day SMA: | 134.63 | Buy |
| 8-day EMA: | 157.06 | Buy |
| 20-day EMA: | 151.09 | Buy |
| 50-day EMA: | 143.18 | Buy |
| 200-day EMA: | 134.95 | Buy |
WisdomTree Emerging Markets Ex-China Fund Earnings Growth & XC Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Ascendis Pharma AS Earnings Growth & ASND Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.82 per share, an increase next quarter of $0.04 per share, an increase this year of $3.21 per share, and an increase next year of $5.31 per share.
WisdomTree Emerging Markets Ex-China Fund Technical Analysis
| Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 04 | 05 | 06 | 07 | 11 | 12 | 13 | 14 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ascendis Pharma AS Technical Analysis
| Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 04 | 05 | 06 | 07 | 11 | 12 | 13 | 14 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||